...
首页> 外文期刊>The Laryngoscope: A Medical Journal for Clinical and Research Contributions in Otolaryngology, Head and Neck Medicine and Surgery, Facial Plastic and Reconstructive Surgery .. >Test/retest repeatability of effect contralateral acoustic stimulation on the magnitudes of distortion product ototacoustic emissions
【24h】

Test/retest repeatability of effect contralateral acoustic stimulation on the magnitudes of distortion product ototacoustic emissions

机译:测试/重新测试对侧声音刺激对失真产物耳声发射幅度的影响的可重复性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objectives/Hypothesis: Contralateral inhibition of distortion product otoacoustic emissions (DPOAE) has become an important tool to assess the functioning of the medial olivocochlear efferents in humans. However, before this measurement can be applied clinically, the test/retest repeatability needs to be established. Therefore, the current study aimed at evaluating intra- and intersession test/retest repeatability of contralateral inhibition of DPOAE at 2f1-f2. Study Design: Prospective Test/Retest Reliability Study. Methods: Contralateral inhibition of DPOAE magnitudes were measured in the right ear of 24 adult male participants. To assess the intrasession repeatability, measurements were repeated without altering the position of the DPOAE probe (single-probe-fit). To assess intersession reliability, measurements were repeated on 8 different days (multiple-probe-fit). Repeatability of inhibition of DPOAE magnitudes was evaluated by Cronbach's alpha, interclass correlations, standard error of measurement, and its 95% confidence interval and smallest detectable difference. Results: DPOAE magnitudes were highly stable and repeatable across different recording sessions. However, test/retest reliability coefficients of DPOAE inhibition magnitudes were less than satisfactory for all the frequencies, in both single-probe-fit and multiple-probe-fit modes. Conclusions: Results of the present study showed that contralateral inhibition magnitudes of DPOAEs varied considerably, even though DPOAEs magnitudes remained essentially the same across different recording sessions. As reliability is an essential aspect of any clinical procedure, it is suggested that at present contralateral inhibition of DPOAEs should not be used clinically to evaluate the medial efferent system. Laryngoscope, 2012
机译:目的/假设:对侧抑制畸变产物耳声发射(DPOAE)已成为评估人类内侧小耳蜗出射功能的重要工具。但是,在此测量可临床应用之前,需要确定测试/重新测试的可重复性。因此,当前的研究旨在评估在2f1-f2时对侧抑制DPOAE的闭会期间和闭会期间测试/重新测试的可重复性。研究设计:前瞻性测试/重新测试可靠性研究。方法:在24名成年男性参与者的右耳中测量DPOAE量的对侧抑制。为了评估会话中的可重复性,在不改变DPOAE探针(单探针拟合)位置的情况下重复进行测量。为了评估休会期间的可靠性,在8个不同的天(多探针拟合)重复测量。通过Cronbach的alpha,类间相关性,标准测量误差及其95%的置信区间和最小的可检测差值来评估DPOAE幅度抑制的可重复性。结果:DPOAE幅度在不同的记录会话中高度稳定且可重复。但是,在单探头拟合和多探头拟合模式下,DPOAE抑制幅度的测试/重新测试可靠性系数对于所有频率均不令人满意。结论:本研究结果表明,即使在不同的记录期间DPOAEs的幅度基本保持相同,DPOAEs的对侧抑制幅度也有很大差异。由于可靠性是任何临床程序的重要方面,因此建议目前对侧抑制DPOAEs不应在临床上用于评估内侧传出系统。喉镜,2012年

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号